Jørn Herrstedt
Member of:
Clinical Oncology
1 - 1 out of 1Page size: 10
- 2009
- Published
Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy
Herrstedt, Jørn, Apornwirat, W., Shaharyar, A., Aziz, Z., Roila, F., Van Belle, S., Russo, M. W., Levin, J., Ranganathan, S., Guckert, M. & Grunberg, S. M., 2009, In: Journal of Clinical Oncology. 27, 32, p. 5363-9 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 182566628
Most downloads
-
55
downloads
Impact of Age, Comorbidity, and FIGO Stage on Treatment Choice and Mortality in Older Danish Patients with Gynecological Cancer: A Retrospective Register-Based Cohort Study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
44
downloads
Similarities and Differences between Danish and American Physicians' Religious Characteristics and Clinical Communication: Two Cross-Sectional Surveys
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
32
downloads
High-dose interleukin-2 and interferon as first-line immunotherapy for metastatic melanoma: long-term follow-up in a large unselected Danish patient cohort
Research output: Contribution to journal › Journal article › Research › peer-review
Published